Beacon Financial Advisory LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 59.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,757 shares of the company's stock after selling 8,590 shares during the period. Beacon Financial Advisory LLC's holdings in Cardinal Health were worth $967,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in Cardinal Health by 3.6% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock worth $297,000 after buying an additional 62 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company's stock worth $2,991,000 after buying an additional 69 shares during the period. Perigon Wealth Management LLC boosted its position in Cardinal Health by 3.2% during the 2nd quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company's stock worth $389,000 after buying an additional 72 shares during the period. Community Bank & Trust Waco Texas boosted its position in Cardinal Health by 1.3% during the 2nd quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company's stock worth $940,000 after buying an additional 74 shares during the period. Finally, Pinnacle Bancorp Inc. boosted its position in Cardinal Health by 11.2% during the 1st quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after buying an additional 77 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Cardinal Health news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares of the company's stock, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company's stock, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by corporate insiders.
Cardinal Health Stock Down 2.5%
Shares of NYSE CAH opened at $154.50 on Friday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The firm has a fifty day simple moving average of $152.07 and a 200 day simple moving average of $150.38. The company has a market capitalization of $36.71 billion, a PE ratio of 23.95, a P/E/G ratio of 1.31 and a beta of 0.71.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter last year, the firm earned $1.84 earnings per share. Cardinal Health's quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is currently 31.63%.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on CAH shares. Leerink Partners cut their target price on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research report on Tuesday, August 12th. Citigroup reiterated a "neutral" rating and set a $170.00 target price (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Bank of America lifted their target price on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. UBS Group reiterated a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Argus set a $189.00 target price on shares of Cardinal Health in a research report on Friday, August 22nd. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $165.93.
Check Out Our Latest Stock Analysis on Cardinal Health
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.